V. D'-argenio and F. Salvatore, The role of the gut microbiome in the healthy adult status, Clin Chim Acta, vol.451, pp.97-102, 2015.

A. Heintz-buschart and P. Wilmes, Human Gut Microbiome: Function Matters, Trends Microbiol, p.2, 2017.

D. Rios-covian, Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health, Front Microbiol, vol.7, 2016.

D. R. Donohoe, The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon, Cell metabolism, vol.13, pp.517-526, 2011.

W. E. Roediger, Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man, Gut, vol.21, pp.793-798, 1980.

E. Lachmandas, Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids, Journal of diabetes research, 2016.

T. Liu, Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-kappaB pathway in RAW264.7 cells, Inflammation, vol.35, pp.1676-1684, 2012.

J. S. Park, E. J. Lee, J. C. Lee, W. K. Kim, and H. S. Kim, Anti-inflammatory effects of short chain fatty acids in IFN-gamma-stimulated RAW 264.7 murine macrophage cells: involvement of NF-kappaB and ERK signaling pathways, International immunopharmacology, vol.7, pp.70-77, 2007.

M. D. Saemann, Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and upregulation of IL-10 production, FASEB journal: official publication of the Federation of American Societies for Experimental Biology, vol.14, pp.2380-2382, 2000.

J. P. Segain, Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease, Gut, vol.47, pp.397-403, 2000.

P. V. Chang, L. Hao, S. Offermanns, and R. Medzhitov, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proceedings of the National Academy of Sciences of the United States of America, vol.111, pp.2247-2252, 2014.

M. C. Cleophas, Suppression of monosodium urate crystal-induced cytokine production by butyrate is mediated by the inhibition of class I histone deacetylases, Annals of the rheumatic diseases, vol.75, pp.593-600, 2016.

M. A. Vinolo, Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils, The Journal of nutritional biochemistry, vol.22, pp.849-855, 2011.

M. R. Shakespear, M. A. Halili, K. M. Irvine, D. P. Fairlie, and M. J. Sweet, Histone deacetylases as regulators of inflammation and immunity, Trends in immunology, vol.32, pp.335-343, 2011.

A. J. Brown, The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids, The Journal of biological chemistry, vol.278, pp.11312-11319, 2003.

L. Poul and E. , Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation, The Journal of biological chemistry, vol.278, pp.25481-25489, 2003.

K. M. Maslowski, Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43, Nature, vol.461, pp.1282-1286, 2009.

C. Sina, G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation, Journal of immunology, vol.183, pp.7514-7522, 2009.

J. H. Cummings, E. W. Pomare, W. J. Branch, C. P. Naylor, and G. T. Macfarlane, Short chain fatty acids in human large intestine, portal, hepatic and venous blood, Gut, vol.28, pp.1221-1227, 1987.

M. A. Vinolo, Tributyrin attenuates obesity-associated inflammation and insulin resistance in high-fat-fed mice, American journal of physiology. Endocrinology and metabolism, vol.303, pp.272-282, 2012.

E. C. Aguilar, Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NFkappaB activation. Nutrition, metabolism, and cardiovascular diseases: NMCD 24, pp.606-613, 2014.

Z. Gao, Butyrate improves insulin sensitivity and increases energy expenditure in mice, Diabetes, vol.58, pp.1509-1517, 2009.

D. Sabatino and A. , Oral butyrate for mildly to moderately active Crohn's disease, Alimentary pharmacology & therapeutics, vol.22, pp.789-794, 2005.

P. Vernia, Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study. Digestive diseases and sciences 45, pp.976-981, 2000.

S. Saeed, Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity, Science, vol.345, 2014.

S. C. Cheng, mTOR-and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity, Science, vol.345, 2014.

S. Bekkering, Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes, Arterioscler Thromb Vasc Biol, vol.34, pp.1731-1738, 2014.

|. Scientific-reports, , vol.9, 2019.

K. Bouter, Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects, Clin Transl Gastroenterol, vol.9, 2018.

J. Quintin, Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes, Cell Host Microbe, vol.12, pp.223-232, 2012.

R. J. Arts, Immunometabolic Pathways in BCG-Induced Trained Immunity, Cell Rep, vol.17, p.11, 2016.

S. Bekkering, L. A. Joosten, J. W. Van-der-meer, M. G. Netea, and N. P. Riksen, The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis, Clinical therapeutics, vol.37, pp.914-923, 2015.

G. Den-besten, Short-Chain Fatty Acids Protect Against High-Fat Diet-Induced Obesity via a PPARgamma-Dependent Switch From Lipogenesis to Fat Oxidation, Diabetes, vol.64, pp.2398-2408, 2015.

N. I. Mcneil, J. H. Cummings, and W. P. James, Short chain fatty acid absorption by the human large intestine, Gut, vol.19, pp.819-822, 1978.

J. G. Bloemen, Short chain fatty acids exchange across the gut and liver in humans measured at surgery, Clin Nutr, vol.28, pp.657-661, 2009.

E. E. Canfora, Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial, 2017.

S. M. Grundy, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, vol.112, pp.2735-2752, 2005.

F. H. Karlsson, Gut metagenome in European women with normal, impaired and diabetic glucose control, Nature, vol.498, pp.99-103, 2013.

L. J. Van-tits, P. N. Demacker, J. De-graaf, H. L. Hak-lemmers, and A. F. Stalenhoef, Alpha-tocopherol supplementation decreases production of superoxide and cytokines by leukocytes ex vivo in both normolipidemic and hypertriglyceridemic individuals, The American journal of clinical nutrition, vol.71, pp.458-464, 2000.